weight loss wegovy - Search News

News

Hims, Wegovy and Novo Nordisk

MarketWatch on MSN · 34m

Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.

Hims & Hers Health Inc.’s stock fell sharply on Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with the telehealth-consultation company less than two months after it started.

HIMS stock plunges as Novo Nordisk severs ties with Hims & Hers over Wegovy sales

Novo Nordisk ends partnership with Hims & Hers over safety and marketing concerns tied to compounded Wegovy, as rivalry with Eli Lilly intensifies.

Stocktwits on MSN · 1h

Hims & Hers Stock Plunges As Novo Nordisk Ends Partnership Over Allegations Of Selling Knockoff Versions Of Wegovy

Shares of Hims & Hers Health Inc. (HIMS) slumped 29% on Monday morning after Danish drug maker Novo Nordisk (NVO) announced that it is halting its collaboration with the telehealth company for the sale of its blockbuster weight loss drug Wegovy.

Wegovy, Lilly Drug Saves Muscle

Bloomberg · 1h

Lilly Drug Saves Muscle When Added to Wegovy Weight-Loss Shot

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while losing weight, offering a potential solution to one of the key problems that’s emerged with popular obesity shots.

Daily Voice on MSN · 23m

Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug Sales

Novo Nordisk has ended its partnership with Hims & Hers Health after two months, accusing the telehealth company of pushing illegal knockoff versions of its weight-loss drug Wegovy and deceptive marketing.

The Wall Street Journal on MSN · 4h

Novo Nordisk’s New Obesity Drug Beats Wegovy Weight Loss in Early Trial

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

34mon MSN

Hims stock tanks over 20% after Wegovy deal collapse — why Novo Nordisk’s breakup over weight loss drugs is shaking up Wall Street

Hims stock took a major hit after Novo Nordisk suddenly ended their Wegovy partnership, causing shares to drop over 20% in a ...

2hon MSN

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%

Novo Nordisk said Hims & Hers has “failed to adhere to the law which prohibits mass sales of compounded drugs” under the ...

2don MSN

Weight loss medication and heart health

There is new guidance on the use of popular weight loss medications like Zepbound and Wegovy to help improve heart health.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results